Cbdmd Inc (YCBD)

$0.23 0.00 (-1.41%)
Market Cap 1.90M
Revenue (ttm) 19.48M
Net Income (ttm) -3.70M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -18.99%
Debt to Equity Ratio 0.00
Volume 1,224,379
Avg Vol 1,390,814
Day's Range N/A - N/A
Shares Out 6.26M
Stochastic %K 24%
Beta 2.58
Analysts Strong Sell
Price Target $2.00

Latest News on YCBD

cbdMD Achieves Key Milestone in UK Novel Food Regulatory Approval

Apr 7, 2025, 7:00 AM EDT - 22 hours ago

cbdMD Achieves Key Milestone in UK Novel Food Regulatory Approval

cbdMD, Inc. (YCBD) Q1 2025 Earnings Call Transcript

Feb 14, 2025, 12:08 PM EST - 7 weeks ago

cbdMD, Inc. (YCBD) Q1 2025 Earnings Call Transcript

cbdMD Generates $5.1 Million in Revenue, Positive Earnings

Feb 13, 2025, 4:10 PM EST - 7 weeks ago

cbdMD Generates $5.1 Million in Revenue, Positive Earnings

cbdMD, Inc. to Host Conference Call to Discuss December 31, 2024 First Quarter of Fiscal Year 2025 Results

Feb 7, 2025, 5:26 PM EST - 2 months ago

cbdMD, Inc. to Host Conference Call to Discuss December 31, 2024 First Quarter of Fiscal Year 2025 Results

cbdMD Announces It Has Fully Satisfied Its Notes

Jan 15, 2025, 10:30 AM EST - 2 months ago

cbdMD Announces It Has Fully Satisfied Its Notes

cbdMD Announces Additional Conversions of Its Convertible Notes

Jan 8, 2025, 5:22 PM EST - 3 months ago

cbdMD Announces Additional Conversions of Its Convertible Notes

cbdMD, Inc. Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standard

Jan 3, 2025, 4:44 PM EST - 3 months ago

cbdMD, Inc. Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standard

cbdMD Announces Company's CEO Joins the Board of Directors

Dec 23, 2024, 3:52 PM EST - 3 months ago

cbdMD Announces Company's CEO Joins the Board of Directors

cbdMD Generates $19.1 Million in Year Over Year Reduction in Net Loss Improvement

Dec 18, 2024, 4:08 PM EST - 3 months ago

cbdMD Generates $19.1 Million in Year Over Year Reduction in Net Loss Improvement

cbdMD, Inc. to Host Conference Call to Discuss September 30, 2024 Fourth Quarter and Fiscal Year 2024 Results

Dec 18, 2024, 11:04 AM EST - 3 months ago

cbdMD, Inc. to Host Conference Call to Discuss September 30, 2024 Fourth Quarter and Fiscal Year 2024 Results

cbdMD, Inc. Reschedules Earnings Release and Conference Call

Dec 17, 2024, 4:42 PM EST - 3 months ago

cbdMD, Inc. Reschedules Earnings Release and Conference Call

cbdMD, Inc. To Host Conference Call to Discuss September 30, 2024 Fourth Quarter and Fiscal Year 2024 Results

Dec 12, 2024, 12:12 PM EST - 4 months ago

cbdMD, Inc. To Host Conference Call to Discuss September 30, 2024 Fourth Quarter and Fiscal Year 2024 Results

cbdMD Launches Herbal Oasis Social Tonics, Hemp-Derived THC Seltzers

Nov 14, 2024, 2:26 PM EST - 5 months ago

cbdMD Launches Herbal Oasis Social Tonics, Hemp-Derived THC Seltzers

cbdMD, Inc. Announces Acceptance of Compliance Plan by NYSE American

Aug 26, 2024, 4:25 PM EDT - 8 months ago

cbdMD, Inc. Announces Acceptance of Compliance Plan by NYSE American

cbdMD, Inc. (YCBD) Q3 2024 Earnings Call Transcript

Aug 14, 2024, 10:00 PM EDT - 8 months ago

cbdMD, Inc. (YCBD) Q3 2024 Earnings Call Transcript

cbdMD Delivers on Sequential Revenue Growth and Positive Net Income for Q3 2024

Aug 14, 2024, 4:10 PM EDT - 8 months ago

cbdMD Delivers on Sequential Revenue Growth and Positive Net Income for Q3 2024

cbdMD, Inc. to Host Conference Call to Discuss Third Quarter of Fiscal 2024 Results

Aug 5, 2024, 11:03 AM EDT - 8 months ago

cbdMD, Inc. to Host Conference Call to Discuss Third Quarter of Fiscal 2024 Results

cbdMD Announces Publication of Human Clinical Trial Data

Jun 27, 2024, 11:45 AM EDT - 10 months ago

cbdMD Announces Publication of Human Clinical Trial Data

cbdMD, Inc. Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standards

Jun 7, 2024, 5:36 PM EDT - 10 months ago

cbdMD, Inc. Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standards

cbdMD Unveils ATRx Labs Premium Mushroom Line at GNC, Expanding cbdMD's Natural Wellness Solutions

May 24, 2024, 10:03 AM EDT - 11 months ago

cbdMD Unveils ATRx Labs Premium Mushroom Line at GNC, Expanding cbdMD's Natural Wellness Solutions

cbdMD Launches Max Chill Dragon Fruit D9 Gummies: Your Go-To Relaxation Blend for the Summer

May 16, 2024, 10:37 AM EDT - 11 months ago

cbdMD Launches Max Chill Dragon Fruit D9 Gummies: Your Go-To Relaxation Blend for the Summer

cbdMD Reports Second Quarter Results

May 15, 2024, 4:09 PM EDT - 11 months ago

cbdMD Reports Second Quarter Results

cbdMD, Inc. to Host Conference Call to Discuss Second Quarter of Fiscal 2024 Results

May 13, 2024, 11:20 AM EDT - 11 months ago

cbdMD, Inc. to Host Conference Call to Discuss Second Quarter of Fiscal 2024 Results

cbdMD Reduces Year over Year Net Loss from Operations by $3.0 Million

Feb 13, 2024, 4:10 PM EST - 1 year ago

cbdMD Reduces Year over Year Net Loss from Operations by $3.0 Million

cbdMD, Inc. to Host Conference Call to Discuss First Quarter of Fiscal 2024 Results

Feb 8, 2024, 4:05 PM EST - 1 year ago

cbdMD, Inc. to Host Conference Call to Discuss First Quarter of Fiscal 2024 Results

cbdMD Welcomes Vice President of Wholesale Sales, Joe Baghadjian- Paving the Way for Future Growth

Feb 8, 2024, 10:10 AM EST - 1 year ago

cbdMD Welcomes Vice President of Wholesale Sales, Joe Baghadjian- Paving the Way for Future Growth

cbdMD Announces Financing of $1,250,000

Feb 2, 2024, 5:00 PM EST - 1 year ago

cbdMD Announces Financing of $1,250,000

cbdMD Unveils THCV+CBG Energy Softgels, Ushering in a New Era of Wellness Solutions

Jan 31, 2024, 10:56 AM EST - 1 year ago

cbdMD Unveils THCV+CBG Energy Softgels, Ushering in a New Era of Wellness Solutions

cbdMD Launches into Sprouts Farmers Market, Bringing Premium CBD Gummies to 175 Stores Nationwide

Jan 18, 2024, 11:50 AM EST - 1 year ago

cbdMD Launches into Sprouts Farmers Market, Bringing Premium CBD Gummies to 175 Stores Nationwide

cbdMD Reduces Year over Year Net Loss from Operations by $55.8 Million

Dec 22, 2023, 4:06 PM EST - 1 year ago

cbdMD Reduces Year over Year Net Loss from Operations by $55.8 Million

cbdMD, Inc. to Host Conference Call to Discuss September 30, 2023 Fourth Quarter and Fiscal Year 2023 Results

Dec 20, 2023, 12:47 PM EST - 1 year ago

cbdMD, Inc. to Host Conference Call to Discuss September 30, 2023 Fourth Quarter and Fiscal Year 2023 Results

cbdMD Wins Awards in Two Categories at Prestigious Best in Biz Awards

Dec 14, 2023, 11:03 AM EST - 1 year ago

cbdMD Wins Awards in Two Categories at Prestigious Best in Biz Awards

cbdMD Announces Cancellation of Special Meeting

Oct 25, 2023, 5:50 PM EDT - 1 year ago

cbdMD Announces Cancellation of Special Meeting

cbdMD Announces Historic Partnership with FIFA-Affiliated Costa Rican Soccer Team

Oct 5, 2023, 9:00 AM EDT - 1 year ago

cbdMD Announces Historic Partnership with FIFA-Affiliated Costa Rican Soccer Team

cbdMD Announces Adjournment of Special Meeting

Sep 22, 2023, 5:02 PM EDT - 1 year ago

cbdMD Announces Adjournment of Special Meeting

Breaking Barriers: cbdMD's Research Validates Safe CBD Upper Dose

Sep 22, 2023, 9:58 AM EDT - 1 year ago

Breaking Barriers: cbdMD's Research Validates Safe CBD Upper Dose

Paw CBD Wins 2023 'Dog Hip & Joint Product of the Year' Pet Innovation Award

Aug 25, 2023, 9:00 AM EDT - 1 year ago

Paw CBD Wins 2023 'Dog Hip & Joint Product of the Year' Pet Innovation Award

cbdMD, Inc. Suspends Monthly Dividend Payment on Its Series A Cumulative Convertible Preferred Stock

Aug 22, 2023, 8:30 AM EDT - 1 year ago

cbdMD, Inc. Suspends Monthly Dividend Payment on Its Series A Cumulative Convertible Preferred Stock

cbdMD Responds to Congressional Request for Information (RFI) on Regulation of CBD Products

Aug 18, 2023, 2:23 PM EDT - 1 year ago

cbdMD Responds to Congressional Request for Information (RFI) on Regulation of CBD Products

cbdMD Demonstrates Strong Year-over-Year Performance, Significantly Reducing Net Loss by $30 Million

Aug 10, 2023, 4:48 PM EDT - 1 year ago

cbdMD Demonstrates Strong Year-over-Year Performance, Significantly Reducing Net Loss by $30 Million

cbdMD, Inc. to Host Conference Call to Discuss Third Quarter of Fiscal 2023 Results

Aug 7, 2023, 10:00 AM EDT - 1 year ago

cbdMD, Inc. to Host Conference Call to Discuss Third Quarter of Fiscal 2023 Results

cbdMD Releases Tropical Hemp-derived THC + CBD Gummy Line to Elevate Consumer Wellness

Aug 3, 2023, 9:00 AM EDT - 1 year ago

cbdMD Releases Tropical Hemp-derived THC + CBD Gummy Line to Elevate Consumer Wellness

cbdMD Announces Migration to E-Commerce Platform, Shopify

Jun 29, 2023, 2:25 PM EDT - 1 year ago

cbdMD Announces Migration to E-Commerce Platform, Shopify

cbdMD Announces Partnership with Medical Advisor, Dr. Lucille Vega

Jun 22, 2023, 9:00 AM EDT - 1 year ago

cbdMD Announces Partnership with Medical Advisor, Dr. Lucille Vega

cbdMD, Inc. (YCBD) Q2 2023 Earnings Call Transcript

May 15, 2023, 7:30 PM EDT - 2 years ago

cbdMD, Inc. (YCBD) Q2 2023 Earnings Call Transcript

cbdMD Stabilizes Revenue and Significantly Improves Operating Results

May 15, 2023, 4:10 PM EDT - 2 years ago

cbdMD Stabilizes Revenue and Significantly Improves Operating Results

cbdMD, Inc. to Host Conference Call to Discuss Second Quarter of Fiscal 2023 Results

May 10, 2023, 2:59 PM EDT - 2 years ago

cbdMD, Inc. to Host Conference Call to Discuss Second Quarter of Fiscal 2023 Results

cbdMD Announces Closing of $2.8 Million Underwritten Public Offering of Common Stock

May 3, 2023, 2:02 PM EDT - 2 years ago

cbdMD Announces Closing of $2.8 Million Underwritten Public Offering of Common Stock

cbdMD Announces Pricing of $2.8 Million Underwritten Public Offering of Common Stock

Apr 30, 2023, 8:51 PM EDT - 2 years ago

cbdMD Announces Pricing of $2.8 Million Underwritten Public Offering of Common Stock

cbdMD Announces Proposed Public Offering of Common Stock

Apr 28, 2023, 4:49 PM EDT - 2 years ago

cbdMD Announces Proposed Public Offering of Common Stock